The Therm Score doesn't give buy or sell recommendations — it's non-personalized historical statistical information. Today West Pharmaceutical Services (WST) has a Therm Score of 99.7 (Hot zone). Across the covered universe (S&P 500, Dow 30 and Nasdaq-100 — 520 assets), when the score has been in the Hot zone, price rose over the following 21 sessions in 63.6% of 11 independent episodes analyzed (median +1.08%, net of trading costs). That's an aggregate historical pattern for the zone, not a personalized recommendation for WST or an assessment of your situation.

MarketTherm doesn't issue buy, sell, or hold ratings for West Pharmaceutical Services or any asset — the Therm Score is a technical positioning indicator, not an analyst recommendation. What it shows instead: WST is in the Hot zone today (99.7/100), and price rose over the following 21 sessions in 63.6% of 11 independent episodes analyzed (median +1.08%, net of trading costs) when the covered universe has scored there historically.

West Pharmaceutical Services (WST) rose 0.90% versus the previous session's close. Its Therm Score moved up 4.6 points over the same period, to 99.7 (Hot zone) today. MarketTherm doesn't attribute daily price moves to specific news or events — for that, see the recent news section below.

According to the Therm Score, West Pharmaceutical Services (WST) is in the Hot zone today (99.7/100), based on normalized technical positioning relative to its own historical range.

MarketTherm doesn't forecast prices or set price targets for West Pharmaceutical Services. Instead of a forecast, here's the historical frequency: across the covered universe, price rose over the following 21 sessions in 63.6% of 11 independent episodes analyzed (median +1.08%, net of trading costs) after a score in the Hot zone. That's a statistical tendency for the zone as a whole, not a prediction for WST specifically.

Yes — looking at WST's own available history (537 sessions), its Therm Score has spent 16.8% of the time in the Hot zone. That's a different measure from the win-rate cited above (how often price rose afterward, across the whole universe) — this one just says how often WST itself has scored in this zone, regardless of what happened to its price next.

Over the past 252 trading sessions (roughly a year), WST has traded between $230.63 and $398.29, versus $398.29 today. This is the stock's own price range — see the next question for its Therm Score range over the same period.

Over the past 252 trading sessions (roughly a year), WST's Therm Score has ranged from 5.2 to 99.7, versus 99.7 today. This tracks the score itself, not the stock price — see the previous question for WST's 52-week price range.

WST has been in the Hot zone for 6 consecutive sessions as of today. A longer streak means the score has been more persistently in this range recently — it isn't, by itself, a signal to act on.

Today, WST's Therm Score of 99.7 ranks 1 of 5 tracked Health Care stocks (WST included), which range from 88.0 to 99.7 today. This is descriptive context for the sector, not a ranking recommendation.

For the Hot zone, the historical share of positive episodes by timeframe has been: 5 sessions — 58.3% (n=12); 10 sessions — 66.7% (n=12); 21 sessions — 63.6% (n=11). Compare across timeframes yourself with the selector above — a pattern that holds up at every horizon is more convincing than one that only appears at a single one.

The Therm Score is only validated for horizons of 5, 10, and 21 trading sessions (roughly one week to one month) — it isn't a fundamental analysis tool and says nothing about West Pharmaceutical Services's prospects as a multi-year holding, its earnings, or its valuation.

It's based on a historical backtest across all 520 assets in the covered universe, using non-overlapping episodes and a strict train/test split by date to check the pattern holds out-of-sample, net of an estimated trading cost — see the Methodology page for the full process. Like any indicator based on past data, it doesn't guarantee future results, and it isn't a substitute for professional financial advice.